TY  - GEN
AU  - Lucas,Fabienne
AU  - Larkin,Karylin
AU  - Gregory,C Thomas
AU  - Orwick,Shelley
AU  - Doong,Tzyy-Jye
AU  - Lozanski,Arletta
AU  - Lozanski,Gerard
AU  - Misra,Shrilekha
AU  - Ngankeu,Apollinaire
AU  - Ozer,Hatice Gulcin
AU  - Sampath,Deepa
AU  - Thangavadivel,Shanmugapriya
AU  - Yilmaz,Selen A
AU  - Rogers,Kerry A
AU  - Byrd,John C
AU  - Woyach,Jennifer A
AU  - Blachly,James S
TI  - Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations
SN  - 1528-0020
PY  - 2021///0208
KW  - Adenine
KW  - analogs & derivatives
KW  - Agammaglobulinaemia Tyrosine Kinase
KW  - genetics
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Mutation
KW  - Phospholipase C gamma
KW  - Piperidines
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Sulfonamides
N1  - Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood.2019003722
ER  -